Лирилумаб

Rec. INN (наименование, зарегистрированное ВОЗ)

USAN (наименование, принятое к употреблению в США)

DB11754

1000676-41-4

immunoglobulin G4-kappa, anti-[Homo sapiens KIR2D subgroup (killer cell immunoglobulin-like receptors from KIRD2 subgroup including KIR2DL1 (nkat1, CD158A), KIR2DL2 (nkat6, CD158B1), KIR2DL3 (nkat2, CD158B2), KIR2DS1 (CD158H) and KIR2DS2 (nkat5, CD158J)], Homo sapiens monoclonal antibody;
gamma4 heavy chain (1-450) [Homo sapiens VH (IGHV1-69*01 (95.90%) -(IGHD)-IGHJ6*01) [8.8.16] (1-123) -IGHG4*01 hinge S10>P (231) (124-450)], (137-214')-disulfide with kappa light chain (1'-214') [Homo sapiens V-KAPPA (IGKV3-11*01 (98.90%) - IGKJ2*01) [6.3.9] (1'-107') -IGKC*01 (108'-214')]; (229-229'':232- 232'')-bisdisulfide dimer

C₆₄₅₂H₉₉₁₈N₁₆₉₈O₂₀₃₀S₄₆

145228,93 г/моль

Поделиться этой страницей